IP Library Granted Patent US 7,223,595
Granted Patent B2
US 7,223,595 · App. 10/944,218 · Granted May 29, 2007

Use of purified

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,595
App. No.
10/944,218
Granted
May 29, 2007
Kind
B2
Abstract

The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease mixture in a single affinity chromatography step and uses of the purified SGT.

Claims (10)

1. A method for production of a biomass of cells comprising the steps of providing an adherent culture of cells, detaching said culture of cells from the maxtrix to which the cells are adhered by contacting the cells with a composition comprising arginine and Streptomyces griseus trypsin (SGT) having a specific activity of at least 25×10 3 U/mg protein, subculturing said cells, and growing the subcultured cells to a biomass.

2. The method according to claim 1 , wherein the cells are grown in serum free medium.

3. The method of claim 1 , further comprising a biological process selected from the group consisting of cell culturing, virus activation, and virus purification, wherein the purified preparation of Streptomyces griseus trypsin (SGT) is used in said further biological process.

4. The cell culture of claim 1 , wherein the cells are primary cells or cells from a continuous cell line.

5. The method of claim 1 , wherein the method further comprises infecting the cells of the biomass with a virus and incubating the cells to propagate the virus.

6. The method of claim 5 , wherein the virus is orthomyxoviridae.

7. The method of claim 5 , wherein the method further comprises adding the purified preparation of Streptomyces griseus trypsin (SGT) to activate said virus and harvesting said virus produced.

8. The method of claim 7 , wherein the method further comprises purifying said virus produced.

9. A method for production of a biomass of cells comprising the steps of providing an adherent culture of cells, detaching said culture from the matrix to which the cells are adhered by contacting the cells with a composition comprising arginine and Streptomyces griseus trypsin (SGT) having a specific activity of at least 25×10 3 U/mg protein, subculturing said cells, and growing the subcultured cells to a biomass, wherein total protease protein load is reduced at least by 75% compared to a cell culture cultivated under identical conditions by use of mammalian-derived trypsin.

10. The method of claim 1 or 9 , wherein the purified SGT is in a solution comprising from about 0.5M arginine to about 1.2M arginine.

Assignments (6)
CHANGE OF NAME Recorded Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 048117/0275 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRESPONDENCE DATA PREVIOUSLY RECORDED ON REEL 037155 FRAME 0732. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 2, 2016
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 038592/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 037155/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2007
From: BAXTER VACCINE AKTIENGESELLSCHAFT
To: BAXTER HEALTHCARE S.A.
Reel/Frame 018936/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2007
From: MITTERER, ARTUR; TAUER, CHRISTA; REITER, MANFRED; MUNDT, WOLFGANG
To: BAXTER VACCINE AKTIENGESELLSCHAFT
Reel/Frame 018871/0079 →